What amount sold does Precision Epigenomics Inc report in Form D filings?

The latest linked filings report $1.4M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Precision Epigenomics Inc's most recent SEC filing?

Precision Epigenomics Inc's most recent Form D filing was on 2025-09-23.

How many investors does Precision Epigenomics Inc have?

The most recent Form D filing lists 5 investor(s).

What type of securities does Precision Epigenomics Inc offer?

Precision Epigenomics Inc's SEC Form D filings indicate debt offerings.

Precision Epigenomics Inc

CIK: 0002017642·Biotechnology·TUCSON, AZ·Corporation·Founded 2021

Reported Sold

$1,382,795

Total Filings

Identified Offerings

Last Filed

Sep 23, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Sep 23, 2025Form D — New notice

Reported sold: $265,000 · Target: $2,000,000

Rule 506(b)·5 investors

Apr 1, 2024Form D — New notice

Reported sold: $1,117,795 · Target: $1,700,591

Rule 506(c)·2 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 2 identified offerings

$1,382,795

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Mark A Nelson

Related Person

Appears on 2 filings

Lisa Shaffer

Related Person

Appears on 2 filings

Richard Bernert

Related Person

Appears on 2 filings

Marie Wesselhoft

Related Person

Appears on 2 filings

Matthew H Miller

Related Person

Appears on 2 filings

Lisa Jensen-Long

Related Person

Appears on 2 filings

Bernard W Futscher

Related Person

Appears on 1 filing

Barnard W Futscher

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Sep 23, 2025	New	$2,000,000	$265,000	5
Apr 1, 2024	New	$1,700,591	$1,117,795	2

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

511 Therapeutics, Inc.

Biotechnology

Offering target: $1,000,000

Filed Oct 30, 2026